Aurobindo Pharma (AUROPHARMA) Share Price rises 3.16% to Rs 1,626
- October 9, 2026
- Posted by: Kunal Singla
- Category: News
Aurobindo Pharma Share Price is in focus today after the stock rose 3.16% to Rs 1,626, taking its market capitalisation to Rs 92,923.53 Cr. Univest data confirms the move itself, though no company-specific trigger has been identified. The move keeps Aurobindo Pharma Share Price, Aurobindo Pharma Share Price Today and Aurobindo Pharma Stock News in focus for readers tracking pharma names in the Indian stock market. The latest Univest figures show that the share price rise was visible from the open itself, and the stock later touched the day’s high at Rs 1,626. Investors watching Aurobindo Pharma Share Price can monitor the next price update alongside valuation, sector benchmark and peer positioning.
Aurobindo Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,626 |
| Previous Close | Rs 1,576.25 |
| Today's Move | Rs 49.75 (+3.16%) |
| Open | Rs 1,575 |
| High | Rs 1,626 |
| Low | Rs 1,548.2 |
| Market Capitalisation | Rs 92,923.53 crore |
| Market Cap Category | Large Cap |
Aurobindo Pharma Ltd. (AUROPHARMA) rose to Rs 1,626 from the previous close of Rs 1,576.25, a move of Rs 49.75 or 3.16%. The stock opened at Rs 1,575, reached a high of Rs 1,626, recorded a low of Rs 1,548.2.
Aurobindo Pharma Share Price is trading higher today after moving from Rs 1,576.25 at the previous close to Rs 1,626, a gain of Rs 49.75 or 3.16%. The stock opened at Rs 1,575, touched a high of Rs 1,626 and a low of Rs 1,548.2, showing a clear intraday range around the current Aurobindo Pharma Share Price. The market capitalisation stood at Rs 92,923.53 Cr. For readers following Aurobindo Pharma Share Price Today, the key point is that the latest move is price-driven and measurable, not narrative-driven. This Aurobindo Pharma Share Price update also places the stock among the day’s notable risers. From here, the more relevant question is how the valuation and operating metrics compare with its sector peers.
Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 92,923.53 crore |
| P/E Ratio | 24.43x |
| P/B Ratio | 2.33x |
| ROE | 9.93% |
| ROCE | 12.76% |
| EPS | Rs 64.52 |
| Book Value Per Share | Rs 676.49 |
| Dividend Yield | 0.25% |
Aurobindo Pharma Ltd. (AUROPHARMA) fundamental metrics show P/E 24.43x, P/B 2.33x, ROE 9.93%, ROCE 12.76%. Read together, these ratios describe the company’s position rather than a recommendation.
Aurobindo Pharma Ltd. has a market capitalisation of Rs 92,923.53 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.43x, P/B at 2.33x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.25%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.23x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 24.43x |
| Benchmark Median P/E | 31.23x |
| Benchmark Average P/E | 45.39x |
| Benchmark P/E Range | 3.4x to 616.23x |
| Company P/B Ratio | 2.33x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 9.93% |
| Benchmark Median ROE | 11.33% |
| Company ROCE | 12.76% |
| Benchmark Median ROCE | 13.25% |
| Company Market Capitalisation | Rs 92,923.53 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 24.43x, which is below the benchmark median of 31.23x, a difference of -21.77%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of 9.93%, which is below the benchmark median of 11.33%, a difference of -12.36%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of 12.76%, which is below the benchmark median of 13.25%, a difference of -3.7%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,310.94 | 83.04 | 13.75 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,73,078.79 | 78.96 | 19.19 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,433.99 | 99.43 | 19.28 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,022.18 | 24.7 | 4.13 | 19.69 | 21.39 |
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 24.43x compared with the displayed peer median of 78.96x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 9.93% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 92,923.53 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma
- Aurobindo Pharma Share Price is up 3.16% today, with the stock last traded at Rs 1,626.
- The market capitalisation of Rs 92,923.53 Cr keeps Aurobindo Pharma Share Price relevant within Healthcare.
- The company’s P/E of 24.43 and P/B of 2.33 make Aurobindo Pharma Share Price easy to compare against pharma peers.
- ROE of 9.93% and ROCE of 12.76% give Aurobindo Pharma Share Price a clear operating return profile.
- EPS, book value and dividend yield add additional context to Aurobindo Pharma Share Price for fundamental analysis.
About Aurobindo Pharma
Aurobindo Pharma Ltd. operates in Healthcare and belongs to the Pharmaceuticals & Drugs industry. Aurobindo Pharma Share Price reflects a business that is tracked through its earnings, valuation and capital efficiency metrics rather than a single-day move. The company’s listed profile is relevant because investors often compare Aurobindo Pharma Share Price with peers that operate in the same industry and benchmark set. Based on the figures in this note, the market is valuing the company at Rs 92,923.53 Cr with a P/E of 24.43 and a P/B of 2.33. For readers following Aurobindo Pharma Share Price, the key company context is its place in a large, widely followed pharma universe where valuation and returns are closely watched. Univest keeps Aurobindo Pharma Share Price alongside sector, industry and peer metrics for a cleaner comparison.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Aurobindo Pharma Share Price rising today?
Ans. Aurobindo Pharma Share Price is rising today because the stock is up 3.16% to Rs 1,626. Univest data confirms the move itself, though no company-specific trigger has been identified.
What is Aurobindo Pharma Share Price today?
Ans. Aurobindo Pharma Share Price today is Rs 1,626. The stock is higher than the previous close of Rs 1,576.25, and the day’s gain is Rs 49.75. The stock moved 3.16% so far today.
How much did Aurobindo Pharma Share Price gain in percentage terms?
Ans. Aurobindo Pharma Share Price gained 3.16% in the latest update. The move followed an opening level of Rs 1,575 and a day high of Rs 1,626. The previous close was Rs 1,576.25.
What is the market capitalisation of Aurobindo Pharma?
Ans. Aurobindo Pharma Share Price is supported by a market capitalisation of Rs 92,923.53 Cr. That size places the company well above the same-industry median market cap of Rs 771.43 Cr.
What is Aurobindo Pharma Share Price valuation?
Ans. Aurobindo Pharma Share Price trades at a P/E of 24.43 and a P/B of 2.33. Both are below the same-industry benchmark median, which gives the stock a useful comparison frame.
How do ROE and ROCE look for Aurobindo Pharma Share Price?
Ans. Aurobindo Pharma Share Price shows ROE of 9.93% and ROCE of 12.76%. Both sit slightly below the same-industry median, so return efficiency remains an important watch point. The previous close was Rs 1,576.25.
What do EPS and book value show for Aurobindo Pharma Share Price?
Ans. Aurobindo Pharma Share Price has EPS of Rs 64.52 and book value of Rs 676.49. EPS reflects earnings attributable to each share, while book value shows the accounting net worth per share.
Does Aurobindo Pharma Share Price look expensive versus peers?
Ans. Aurobindo Pharma Share Price is lower on P/E and P/B than several large pharma peers, including Sun Pharma and Divi's Laboratories. That makes the stock easier to compare on valuation, not a forecast.
Track Aurobindo Pharma Share Price on Univest
Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Aurobindo Pharma Share Price on Univest for live share price updates, valuation ratios, market capitalisation, 52-week levels and market insights. The same page also helps users monitor Aurobindo Pharma Share Price Today alongside fundamental ratios and company context. If you want a single place for Aurobindo Pharma Share Price, Aurobindo Pharma Stock News and related stock analysis, Univest keeps the key numbers in one view.
